Recently, three clinical studies found that OPN plasma levels were significantly associated with progression-free survival and overall survival in patients with advanced NSCLC who received either chemotherapy or radiotherapy [23, 25, 40]. This evidence concerns the gene SPP1 and non-small cell lung carcinoma.